Paclitaxel + Carboplatin With AVB-S6-500 in Women With Stage III or IV Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Receiving Neoadjuvant Chemotherapy
Stopped Trial may move forward as an NCI-sponsored trial and not an investigator initiated trial.
Conditions
- Epithelial Ovarian Cancer
- Primary Peritoneal Carcinoma
- Fallopian Tube Cancer
Interventions
- DRUG: AVB-S6-500
- DRUG: Paclitaxel
- DRUG: Carboplatin
- PROCEDURE: Tissue from Diagnostic Laparoscopy
- PROCEDURE: Tissue from Core biopsy
- PROCEDURE: Interval Debulking
- PROCEDURE: Peripheral blood
- PROCEDURE: Ascites collection
Sponsor
Washington University School of Medicine
Collaborators